Reportlinker Adds Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
NEW YORK, April 12, 2011 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:
Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016
Summary
GlobalData's new report, "Continuous Glucose Monitoring (CGM) Systems - Global Pipeline Analysis, Opportunity Assessment and Market Forecasts to 2016" provides key data, information and analysis on the global Continuous Glucose Monitoring (CGM) systems market. The report provides market landscape, competitive landscape and market trends information on the Continuous Glucose Monitoring (CGM) systems market. The report provides comprehensive information on the key trends affecting the market, and key analytical content on the market dynamics. The report also reviews the competitive landscape and technology offerings.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Scope
- Key geographies covered include the US, Canada, the UK, Germany, China, India, and Australia.
- Annualized market revenues data from 2005 to 2009, forecast forward for 7 years to 2016. Company shares data for 2009.
- Qualitative analysis of key market trends, market drivers, and restraints by each category within Continuous Glucose Monitoring (CGM) systems market.
- The report also covers information on the leading market players, the competitive landscape, and the leading pipeline products and technologies.
- Key players covered include Medtronic, DexCom and Abbott Laboratories.
Reasons to buy
- Develop business strategies by understanding the trends and developments that are driving the Continuous Glucose Monitoring (CGM) systems market globally.
- Design and develop your product development, marketing and sales strategies.
- Develop market-entry and market expansion strategies.
- Identify key players best positioned to take advantage of the emerging market opportunities.
- Exploit in-licensing and out-licensing opportunities by identifying products, most likely to ensure a robust return.
- What's the next big thing in the Continuous Glucose Monitoring (CGM) systems market landscape? – Identify, understand and capitalize.
- Make more informed business decisions from the insightful and in-depth analysis of the global Continuous Glucose Monitoring (CGM) systems market and the factors shaping it.
1 Table of contents
1 Table of contents 2
1.1 List of Tables 4
1.2 List of Figures 5
2 Introduction 6
2.1 GlobalData Report Guidance 6
3 Disease Overview 7
3.1 Diabetes 7
3.2 Epidemiology 7
4 Continuous Glucose Monitoring (CGM) Systems – Overview 9
4.1 Cost Analysis for CGM Systems 9
5 Continuous Gluose Monitoring Systems – Market Characterization 10
5.1 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Historic, 2005–2009 10
5.2 Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), Forecast, 2009-2016 11
5.3 Continuous Glucose Monitoring Systems, Market Dynamics 12
5.3.1 Continuous Glucose Monitoring Systems, Market Drivers 12
5.3.2 Continuous Glucose Monitoring Systems, Market Restraints 14
6 Continuous Glucose Monitoring Systems Market, by Country, Revenue ($m), 2005-2016 16
6.1 Continuous Glucose Monitoring Systems Market, US, Revenue ($m), Historic, 2005–2009 16
6.2 Continuous Glucose Monitoring Systems Market, US, Revenue ($m), Forecast, 2009–2016 17
6.3 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), Historic, 2006–2009 18
6.4 Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), Forecast, 2009–2016 19
6.5 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), Historic, 2007–2009 20
6.6 Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), Forecast, 2009–2016 21
6.7 Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), Historic, 2008–2009 22
6.8 Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), Forecast, 2009–2016 23
6.9 Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), Historic, 2007–2009 24
6.10 Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), Forecast, 2009–2016 25
6.11 Continuous Glucose Monitoring Systems Market, Italy, Revenue ($000s), Historic, 2008–2009 26
6.12 Continuous Glucose Monitoring Systems Market, Italy, Revenue ($m), Forecast, 2009–2016 27
6.13 Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), Historic, 2005–2009 28
6.14 Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), Forecast, 2009–2016 29
6.15 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), Historic, 2007–2009 30
6.16 Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), Forecast, 2009–2016 31
6.17 Continuous Glucose Monitoring Systems Market, China, Revenue ($m), Historic, 2005–2009 32
6.18 Continuous Glucose Monitoring Systems Market, China, Revenue ($m), Forecast, 2009–2016 33
6.19 Continuous Glucose Monitoring Systems Market, India, Revenue ($m), Historic, 2005–2009 34
6.20 Continuous Glucose Monitoring Systems Market, India, Revenue ($m), Forecast, 2009–2016 35
6.21 Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), Historic, 2005–2009 36
6.22 Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), Forecast, 2009–2016 37
7 Continuous Glucose Monitoring Systems, Global, Key Company Shares 38
7.1 Continuos Glucose Monitoring Systems: Key Market Participants 39
7.1.1 Medtronic, Inc. 39
7.1.2 DexCom, Inc. 40
7.1.3 Abbott Diabetes Care, Inc. (Subsidiary of Abbott Laboratories) 41
8 Key Continuous Glucose Monitoring Systems in the Market 42
8.1 Abbott FreeStyle Navigator 42
8.1.1 Overview 42
8.1.2 Clinical Trial Details 42
8.2 Medtronic's MiniMed Paradigm REAL-Time System 43
8.2.1 Overview 43
8.3 Medtronic's MiniMed Guardian REAL-Time System 44
8.3.1 Overview 44
8.4 DexCom SEVEN PLUS 44
8.4.1 Overview 44
9 Continuous Glucose Monitoring Systems Market, Pipeline Assessment 45
9.1 Profiles of Promising Continuous Glucose Monitoring Systems Under Clinical Development 46
9.1.1 EyeSense Blood Glucose Measurement Device 46
9.1.2 HypoMon 47
9.1.3 MicroEye 49
9.1.4 NBM-200G 49
9.1.5 Optical Hypoglycemia Detector 51
9.1.6 OptiScanner 5000 51
9.1.7 Glucoday S 53
9.1.8 iGlyko system 55
10 Global Continuous Glucose Monitoring Systems Market: – Strategic Deals Analysis 59
10.1 Key Deals 59
10.1.1 Bayer HealthCare AG, a Subsidiary of Bayer AG, Completed the Acquisition of iSense Corporation 59
11 Appendix 60
11.1 Definitions 61
11.1.1 Continuous Glucose Monitoring Systems 61
11.2 Acronyms 61
11.3 Sources 62
11.4 Research Methodology 62
11.5 Secondary Research 63
11.6 Primary Research 63
11.7 Models 63
11.8 Forecasts 64
11.9 Expert Panels 64
11.10 GlobalData Consulting 64
11.11 Contact Us 64
11.12 Disclaimer 64
1.1 List of Tables
Table 1: Diabetes, Major Countries, Estimated Prevalence (Million), 2010 and 2030 8
Table 2: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2005–2009 10
Table 3: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2009–2016 11
Table 4: Disposable Income, Emerging Countries ($), (2002-2008) 14
Table 5: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2005–2009 16
Table 6: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2009–2016 17
Table 7: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2006–2009 18
Table 8: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2009–2016 19
Table 9: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2007–2009 20
Table 10: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2009–2016 21
Table 11: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2008–2009 22
Table 12: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2009–2016 23
Table 13: Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), 2007–2009 24
Table 14: Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), 2009–2016 25
Table 15: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($000s), 2008–2009 26
Table 16: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($m), 2009–2016 27
Table 17: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), 2005–2009 28
Table 18: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), 2009–2016 29
Table 19: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2007–2009 30
Table 20: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2009–2016 31
Table 21: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2005–2009 32
Table 22: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2009–2016 33
Table 23: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2005–2009 34
Table 24: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2009–2016 35
Table 25: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), 2005–2009 36
Table 26: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), 2009–2016 37
Table 27: Continuous Glucose Monitoring Systems Market, Global, Key Company Share, Revenue ($m), 2009 38
Table 28: Medtronic, Inc. Marketed Products, 2010 39
Table 29: Medtronic, Inc. Pipeline Products, 2010 39
Table 30: DexCom, Marketed Products, 2010 40
Table 31: DexCom, Pipeline Products, 2010 40
Table 32: Abbott Diabetes Care, Marketed Products, 2010 41
Table 33: Abbott FreeStyle Navigator, Features and Benefits 42
Table 34: MiniMed Paradigm REAL-Time System, Features and Benefits 43
Table 35: MiniMed Guardian REAL-Time System, Features and Benefits 44
Table 36: DexCom SEVEN PLUS, Features and Benefits 44
Table 37: Pipeline Technology Assessment for Continuous Glucose Monitoring by Development Stage, Global 45
Table 38: Investigation of a Sub-Conjunctival Insert 46
Table 39: EyeSense Blood glucose measurement device, Product Status, 2010 47
Table 40: Clinical Evaluation of a Non-invasive Alarm System HypoMon for Nocturnal Hypoglycemia 48
Table 41: HypoMon, Product Status, 2010 48
Table 42: MicroEye, Product Status, 2010 49
Table 43: Clinical Trial to Measure Safety, Accuracy And Efficacy Of NBM-200G in Glucose Monitoring 50
Table 44: NBM-200G, Product Status, 2010 50
Table 45: Optical Hypoglycemia Detector, Product Status, 2010 51
Table 46: Evaluation Of A Mid-Infrared Glucose Monitor On Critically Ill Patients 52
Table 47: OptiScanner 5000 , Product Status, 2010 53
Table 48: Evaluation of Different Techniques for Subcutaneous Glucose Monitoring in Type 1 Diabetic Patients During Real-Life Glucose Excursions 54
Table 49: Glucoday S, Product Status, 2010 54
Table 50: iGlyko system, Product Status, 2010 55
Table 51: Continuous Glucose Monitoring Systems (Non-Invasive Systems), Pipeline Summary, 2010 56
Table 52: Continuous Glucose Monitoring Systems (Minimally Invasive Systems), Pipeline Summary, 2010 57
Table 53: Continuous Glucose Monitoring Systems, Pipeline Summary, 2010 58
1.2 List of Figures
Figure 1: Diabetes, Major Countries, Estimated Prevalence (Million), 2010 and 2030 7
Figure 2: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2005–2009 10
Figure 3: Continuous Glucose Monitoring Systems Market, Global, Revenue ($m), 2009–2016 11
Figure 4: Continuous Glucose Monitoring Systems Market, Drivers and Restraints 12
Figure 5: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2005–2009 16
Figure 6: Continuous Glucose Monitoring Systems Market, US, Revenue ($m), 2009–2016 17
Figure 7: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2006–2009 18
Figure 8: Continuous Glucose Monitoring Systems Market, Canada, Revenue ($m), 2009–2016 19
Figure 9: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2007–2009 20
Figure 10: Continuous Glucose Monitoring Systems Market, Germany, Revenue ($m), 2009–2016 21
Figure 11: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2008–2009 22
Figure 12: Continuous Glucose Monitoring Systems Market, UK, Revenue ($m), 2009–2016 23
Figure 13: Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), 2007–2009 24
Figure 14: Continuous Glucose Monitoring Systems Market, France, Revenue ($000s), 2009–2016 25
Figure 15: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($000s), 2008–2009 26
Figure 16: Continuous Glucose Monitoring Systems Market, Italy, Revenue ($m), 2009–2016 27
Figure 17: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), 2005–2009 28
Figure 18: Continuous Glucose Monitoring Systems Market, Spain, Revenue ($000s), 2009–2016 29
Figure 19: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2007–2009 30
Figure 20: Continuous Glucose Monitoring Systems Market, Australia, Revenue ($m), 2009–2016 31
Figure 21: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2005–2009 32
Figure 22: Continuous Glucose Monitoring Systems Market, China, Revenue ($m), 2009–2016 33
Figure 23: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2005–2009 34
Figure 24: Continuous Glucose Monitoring Systems Market, India, Revenue ($m), 2009–2016 35
Figure 25: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), 2005–2009 36
Figure 26: Continuous Glucose Monitoring Systems Market, Brazil, Revenue ($000s), 2009–2016 37
Figure 27: Continuous Glucose Monitoring Systems Market, Global, Key Company Share (%), 2009 38
Figure 28: Key Continuous Glucose Monitoring Systems in the Market 42
Figure 29: Pipeline Technology Assessment for Continuous Glucose Monitoring by Development Stage, Global 45
To order this report:
Check our Company Profile, SWOT and Revenue Analysis!
Contact:
Nicolas Bombourg
Reportlinker
Email: [email protected]
US: (805)652-2626
Intl: +1 805-652-2626
SOURCE Reportlinker
Share this article